Patients who had mRCC with sarcomatoid features in the primary tumor and who were treated with VEGF-targeted therapy were retrospectively identified. Pathology slides were reviewed to determine the ...

Because of its rarity, the highly aggressive undifferentiated sarcomatoid carcinoma (USC) subtype of pancreatic ductal adenocarcinoma (PDAC) remains poorly characterized, and thus, therapies targeting ...

Of the 709 patients included in the analysis, 86% had clear cell histology, 7% had papillary histology, 1% had chromophobe histology, and 6% were unclassified. A total of 105 patients received ...

The 3-year cancer-specific survival rate in patients with sarcomatoid differentiation was 30.1% in 2016-2020 and 6.7% in 2010-2015 (P <.0001).

Patients with sarcomatoid RCC are known to have a poor prognosis, as approximately 60% to 80% present with advanced or late-stage disease, according to study author Kyle A. Blum, MD, chief ...

Several factors associated with a diminished response to immune checkpoint inhibitor (ICI) drugs among patients with metastatic clear cell renal cell carcinoma (ccRCC) have been identified. They ...

“Sarcomatoid tumors are highly resistant to anti-cancer therapies, and many patients run out of available treatment options. Our findings might have unveiled a druggable ‘Achilles Heel ...

Read more Patient, 56, dies from colon cancer after just ONE WEEK of symptoms A 56-year-old man from Lebanon died of colonic sarcomatoid carcinoma after suffering symptoms for just one week before ...